Total tau levels are significantly decreased in the healthy older brains compared to the younger brains. by Shreyasi Chatterjee (3531506)

“…Regression plot showing an increased trend of PHF1/Tau signal in the older cohorts compared to the younger group in resected tissue samples (B iii) In post-mortem samples n = 6 (older brains 70–74 years), n = 6 (younger brains 20–33 years), in resected tissue samples n = 13 (older brains 50–70 years and younger brains 19–42 years). …”

Encapsulation efficiency significantly decreases with increasing starting bacterial concentration. by Kelly C. Freudenberger Catanzaro (6701789)

“…Encapsulation efficiency decreased with increasing starting bacterial concentrations. …”

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

Subjects:

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. by Rene Bilingwe Ayiseh (6900296)

Study sample characteristics by groups. by Faranak Mahmoudi Alami (18309967)

Subjects:

Average effect size decreased as sample size increased for all types of analyses (<i>p</i> < .001). by Luke J. Ney (12621627)

Subjects:

Trend of TI values with age: The TI values decreased significantly with the increase of age, * p<0.01 vs other groups. by Yunmeng Da (707943)

Gut and nasal microbiome features have significantly different pairwise distance distributions compared to null expectation. by Holly Kristin Arnold (14204655)

“…For each group, the observed <i>D</i> statistic was calculated by comparing the observed pairwise distances against a random sampling of nodes using the KS test and is indicated by colored bars. …”

BMR decreases with age. by Henrik H. Berntsen (11767710)

Subjects:

Early-stage and mature B lymphocytes significantly decreased but long-lived B lymphocytes increased in APRIL^-/-/BLyS^-/- group. by Natalie M. Bath (6316517)

Subjects:

Venn diagram to illustrate the distribution and overlap of significant lipid metabolites across the different comparisons. by Laia Bertran (3685147)

Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test. by Maria Anna Donati (6735548)

Subjects:

The combination of CUMS and smoke exposure significantly decreased the expression of pro-apoptosis factors and increase in anti-apoptosis factors when compared to stress or smoke group in the left lung. by Bai-Ping Liu (14164799)

Subjects:

Lysosomal area is significantly decreased and lysosomal distribution is altered in FcRn KO podocytes compared to WT after treatment with immune complexes. by George Haddad (470789)

Number and % of participants demonstrating a clinically-significant difference on RMSSD HRV (comparing compassion or relaxation task to control). by Iona Naismith (14581268)

Subjects:

Principal Component Analysis (PCA) to illustrate the distribution of the significant lipid metabolites among the groups (NL, SS and MASH). by Laia Bertran (3685147)

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)